PostEra codevelopment deal with NeuroLucent for Alzheimer’s disease
Posted on28 Nov 2020
Comments0
Biotechnology company PostEra announced a collaboration with NeuroLucent, a Chicago-based company focused on developing novel treatments for Alzheimer’s disease and other dementias.... Read More
What is difference between Proof of concept (PoC) Proof of Principle Studies (PoP) in Drug Discovery?
PoP stands for Proof of Principle studies. PoC stands for Proof of Concept. Proof of concept (PoC) and Proof of Principle Studies... Read More
Importance of Project Manager in Pharmaceutical Industry
Drug development is unpredictable The course of drug development is unpredictable and therefore it is critical to have realistic expectations for any... Read More